Founded in 2006, Meril is an India-based global medical device company dedicated to the innovation, design, and development of novel, clinically relevant, and state-of-the-art devices. As a leading healthcare solutions company, Meril aims to alleviate human suffering and improve the quality of life through R&D, innovation in manufacturing medical technology, scientific communication, and contemporary distribution avenues.
Meril manufactures medical solutions in the form of vascular intervention devices, orthopedic implants, robotics, endo-surgery, ENT products, and in-vitro diagnostics. The company collaborates with physicians and global innovators to identify unmet clinical needs and develop revolutionary therapies. Headquartered in India with over 4000 employees, Meril operates in more than 100 countries and has subsidiaries in India, USA, Germany, Brazil, Russia, South Africa, Bangladesh, and Turkey.
Meril Vascular Intervention has developed new concepts in engineering with a diverse portfolio including drug-eluting stents, bioresorbable scaffolds, balloon catheters, peripheral vascular, and transcatheter aortic valve replacement systems. All products are clinically backed by numerous studies and supported by a team of global scientific advisors. Meril's unique and integrated manufacturing system ensures backward integration, flawless man-material movement, and strong validation.
Meril offers an impressive array of cardiovascular devices, including mechanical and bioprosthetic heart valves used in various valve replacement procedures. The company also has a robust portfolio of cardiac surgery devices, such as intra-coronary shunts and intra-aortic balloon catheter kits, which enhance patient outcomes during surgeries.